Børsen (Right/financial)

When Lars Fruergaard Jørgensen, CEO of Novo Nordisk, has been chosen as person of the year by the Financial Times, it gives us something to think about. The international discussion is about the perspectives that open up as we try to understand the drugs that Novo Nordisk has developed.